L
Laura Scaramucci
Researcher at University of Rome Tor Vergata
Publications - 125
Citations - 1736
Laura Scaramucci is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Anemia & Rituximab. The author has an hindex of 19, co-authored 125 publications receiving 1514 citations.
Papers
More filters
Journal ArticleDOI
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients.
Wilma Barcellini,Bruno Fattizzo,Anna Zaninoni,Tommaso Radice,Ilaria Nichele,Eros Di Bona,Monia Lunghi,C Tassinari,Fiorella Alfinito,Antonella Ferrari,Anna Paola Leporace,Pasquale Niscola,Monica Carpenedo,Carla Boschetti,Nicoletta Revelli,Maria Antonietta Villa,Dario Consonni,Laura Scaramucci,Paolo de Fabritiis,Giuseppe Tagariello,Gianluca Gaidano,Francesco Rodeghiero,Agostino Cortelezzi,Alberto Zanella +23 more
TL;DR: Predictors of a fatal outcome were severe infections, particularly in splenectomized cases, acute renal failure, Evans syndrome, and multitreatment (4 or more lines).
Journal ArticleDOI
Treatment and Clinical Management of Primary Mediastinal Large B-Cell Lymphoma With Sclerosis: MACOP-B Regimen and Mediastinal Radiotherapy Monitored by 67Gallium Scan in 50 Patients
Pier Luigi Zinzani,Maurizio Martelli,Massimo Magagnoli,Edoardo Pescarmona,Laura Scaramucci,Francesca Palombi,Maurizio Bendandi,Maria Paola Martelli,Stefano Ascani,Giulio Fraternali Orcioni,Stefano Pileri,Franco Mandelli,Sante Tura +12 more
TL;DR: In patients with PMLBCL with sclerosis, MACOP-B plus radiation therapy is a very useful first-line treatment and radiation therapy may play an important role and (67)GaSPECT should be considered the imaging technique of choice at least in patients who show CT positivity.
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Treatment and Clinical Management of Primary Mediastinal Large B-Cell Lymphoma With Sclerosis: MACOP-B Regimen and Mediastinal Radiotherapy Monitored by 67 Gallium Scan in 50 Patients
Pier Luigi Zinzani,Maurizio Martelli,Massimo Magagnoli,Edoardo Pescarmona,Laura Scaramucci,Francesca Palombi,Maurizio Bendandi,Maria Paola Martelli,Stefano Ascani,Fraternali Orcioni,Stefano Pileri,Franco Mandelli,Sante Tura +12 more
TL;DR: In this article, the authors evaluated the efficacy of a combined modality treatment (MACOP-B plus mediastinal radiotherapy) and the advantages of Gallium-67-citrate single-photon emission (67GaSPECT) over computed tomography (CT) for restaging in patients with PMLBCL with MS.
Journal ArticleDOI
Mucositis in patients with hematologic malignancies: an overview
Pasquale Niscola,Claudio Romani,Luca Cupelli,Laura Scaramucci,Andrea Tendas,Teresa Dentamaro,Sergio Amadori,Paolo de Fabritiis +7 more
TL;DR: In the last decade, a better insight into the pathogenesis of the mucosal damage has led to the development of novel therapeutic options which potentially could allow a targeted approach to mucositis.
Journal ArticleDOI
The use of major analgesics in patients with renal dysfunction.
Pasquale Niscola,Laura Scaramucci,Gisella Vischini,Marco Giovannini,Michele Ferrannini,Pasquale Massa,Paola Tatangelo,Massimo Galletti,Roberto Palumbo +8 more
TL;DR: The results of this review show that the half-life of the parent opioid compounds and of their metabolites is increased in the presence of renal dysfunction, for which careful monitoring of the patient, dose reduction and a longer time interval between doses are recommended.